RSV Vaccine Eligibility Expands - Quiz - MDSpire

RSV Vaccine Eligibility Expands

Trial data show noninferior immune response in high-risk adults aged 18 to 49 years.

By
Kathryn Wighton
March 13, 2026
3 min

MDSpire News

Share

Original Source(s)

Mdspire News

RSV Vaccine Eligibility Expands

by Kathryn Wighton
March 13, 2026

Related Content

Jama Network Open

Incidence of Recurrent Invasive Pneumococcal Disease in Canada

by Leah J. Ricketson, Altynay Shigayeva, Irina Rajakumar, Zoe Zhong, Kazi Hassan, Irene Martin, Alyssa Golden, Allison J. McGeer, James D. Kellner, Calgary Area Epidemiology Research Group and the Toronto Invasive Bacterial Diseases Network, Chingiz Amirov, Neil Rau, Danny Chen, Jeff Powis, Amna Faheem, Kevin Katz, Valerie Sales, Samir Patel, Abdelbaset Belhaj, Reena Lovinsky, David Rose, Christie Vermeiren, Tony Mazzulli, Jennie Johnstone, Karen Green, Michael Lingley, Andrew Simor, Samira Mubareka, Sigmund Krajden, Larissa Matukas, Sharon Walmsley, Medina Saffie, Daniel Ricciuto, Krystyna Ostrowska, David Richardson, Shannon N Pyra, Joslyn D Gray
July 7, 2026

Kaiser Family Foundation (Kff)

Poll: People Without a Trusted Health Care Provider Are More Likely to Endorse Vaccine Myths, As Are Those Who Often Use Social Media or AI for Health Information

by kffrainl
June 30, 2026

Frontiers In Immunology

Distal and local mucosal immunization with a BoHV-4-based vector delivering CpHV-1 gD confers protection against intravaginal CpHV-1 challenge in goats